Literature DB >> 28486448

Reprogramming the diseased brain.

Stephen B Dunnett1, Anne E Rosser1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28486448     DOI： 10.1038/nbt.3869

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

Authors:  O Lindvall; P Brundin; H Widner; S Rehncrona; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell; C D Marsden
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

2.  Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer.

Authors:  William J Marks; Tiffany L Baumann; Raymond T Bartus
Journal:  Hum Gene Ther       Date:  2016-02-24       Impact factor: 5.695

Review 3.  Direct neuronal reprogramming: learning from and for development.

Authors:  Giacomo Masserdotti; Sergio Gascón; Magdalena Götz
Journal:  Development       Date:  2016-07-15       Impact factor: 6.868

4.  Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.

Authors:  R Mark Richardson; Adrian P Kells; Kathryn H Rosenbluth; Ernesto Aguilar Salegio; Massimo S Fiandaca; Paul S Larson; Philip A Starr; Alastair J Martin; Russell R Lonser; Howard J Federoff; John R Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2011-02-22       Impact factor: 11.454

5.  Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.

Authors:  Pia Rivetti di Val Cervo; Roman A Romanov; Giada Spigolon; Débora Masini; Elisa Martín-Montañez; Enrique M Toledo; Gioele La Manno; Michael Feyder; Christian Pifl; Yi-Han Ng; Sara Padrell Sánchez; Sten Linnarsson; Marius Wernig; Tibor Harkany; Gilberto Fisone; Ernest Arenas
Journal:  Nat Biotechnol       Date:  2017-04-10       Impact factor: 54.908

6.  Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.

Authors:  Massimiliano Caiazzo; Maria Teresa Dell'Anno; Elena Dvoretskova; Dejan Lazarevic; Stefano Taverna; Damiana Leo; Tatyana D Sotnikova; Andrea Menegon; Paola Roncaglia; Giorgia Colciago; Giovanni Russo; Piero Carninci; Gianni Pezzoli; Raul R Gainetdinov; Stefano Gustincich; Alexander Dityatev; Vania Broccoli
Journal:  Nature       Date:  2011-07-03       Impact factor: 49.962

7.  Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells.

Authors:  Xinjian Liu; Fang Li; Elizabeth A Stubblefield; Barbara Blanchard; Toni L Richards; Gaynor A Larson; Yujun He; Qian Huang; Aik-Choon Tan; Dabing Zhang; Timothy A Benke; John R Sladek; Nancy R Zahniser; Chuan-Yuan Li
Journal:  Cell Res       Date:  2011-11-22       Impact factor: 25.617

8.  Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.

Authors:  Erik Cederfjäll; Nathalie Nilsson; Gurdal Sahin; Yaping Chu; Elisabeth Nikitidou; Tomas Björklund; Jeffrey H Kordower; Deniz Kirik
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.

Authors:  Shane Grealish; Elsa Diguet; Agnete Kirkeby; Bengt Mattsson; Andreas Heuer; Yann Bramoulle; Nadja Van Camp; Anselme L Perrier; Philippe Hantraye; Anders Björklund; Malin Parmar
Journal:  Cell Stem Cell       Date:  2014-11-06       Impact factor: 24.633

10.  Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.

Authors:  Gioele La Manno; Daniel Gyllborg; Simone Codeluppi; Kaneyasu Nishimura; Carmen Salto; Amit Zeisel; Lars E Borm; Simon R W Stott; Enrique M Toledo; J Carlos Villaescusa; Peter Lönnerberg; Jesper Ryge; Roger A Barker; Ernest Arenas; Sten Linnarsson
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.